Filtern nach
Letzte Suchanfragen

Ergebnisse für *

Zeige Ergebnisse 1 bis 2 von 2.

  1. Regional differences in the efficiency of health production
    an artefact of spatial dependence?
    Erschienen: June 2009
    Verlag:  RWI, Essen

    The inefficiency of health care provision presents a major health policy concern in Germany. In order to address the issue of efficiency comprehensively - i.e. at the level of the entire system of health care provision rather than individual service... mehr

    Niedersächsische Staats- und Universitätsbibliothek Göttingen
    keine Fernleihe
    Leibniz-Institut für Wirtschaftsforschung Halle, Bibliothek
    keine Fernleihe
    Staats- und Universitätsbibliothek Hamburg Carl von Ossietzky
    keine Fernleihe
    ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel
    DS 10 (112)
    keine Fernleihe
    ifo Institut für Wirtschaftsforschung an der Universität München, Bibliothek
    keine Fernleihe

     

    The inefficiency of health care provision presents a major health policy concern in Germany. In order to address the issue of efficiency comprehensively - i.e. at the level of the entire system of health care provision rather than individual service providers - empirical analyses are often based on data at the regional level. However, regional efficiencies might be subject to spatial dependence, rendering any analysis biased that aims at identifying the determinants of efficiency differentials. We address this issue by specifying a spatial auto- regressive model to explain efficiency scores for German districts which we derive through data envelopment analysis. Regression results suggest that spatial dependence is not a dominant feature in the data. Hence, ignoring spatial interdependence is unlikely to severely bias results of efficiency analyses based on regional data. This holds, in particular, for the role of the states in the efficiency of health production. Significant heterogeneity among states is found in the data regardless of whether or not spatial dependence is accounted for. -- Health production ; data envelopment analysis ; spatial auto- regressive model

     

    Export in Literaturverwaltung   RIS-Format
      BibTeX-Format
    Hinweise zum Inhalt
    Volltext (kostenfrei)
    Quelle: Verbundkataloge
    Sprache: Englisch
    Medientyp: Ebook
    Format: Online
    ISBN: 9783867881258
    Weitere Identifier:
    hdl: 10419/29903
    Schriftenreihe: Ruhr economic papers ; 112
    Schlagworte: Gesundheitsversorgung; Effizienz; Räumliche Interaktion; Autokorrelation; Data-Envelopment-Analyse; Schätzung; Deutschland
    Umfang: Online-Ressource (16 S.), graph. Darst.
    Bemerkung(en):

    Parallel als Druckausg. erschienen

  2. Dealing with excessive off-label drug use
    liability vs. patent prolongation
    Erschienen: June 2009
    Verlag:  RWI, Essen

    The US and the EU recently introduced regulation to curb the extent of risky off-label drug use. It offers manufacturers a prolongation of patent protection or exclusivity if they invest in pediatric clinical tests. This paper shows that a... mehr

    Universitätsbibliothek Braunschweig
    keine Fernleihe
    Niedersächsische Staats- und Universitätsbibliothek Göttingen
    keine Fernleihe
    Staats- und Universitätsbibliothek Hamburg Carl von Ossietzky
    keine Fernleihe
    ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel
    DS 10 (114)
    keine Fernleihe
    ifo Institut für Wirtschaftsforschung an der Universität München, Bibliothek
    keine Fernleihe

     

    The US and the EU recently introduced regulation to curb the extent of risky off-label drug use. It offers manufacturers a prolongation of patent protection or exclusivity if they invest in pediatric clinical tests. This paper shows that a reinforcement of physician liability for off-label use may be the preferred instrument for achieving dynamic efficiency. The liability threat reduces the demand for off-label use, giving manufacturers an appropriate incentive to invest in extended approval. By contrast, patent prolongation does not affect physicians' prescription decisions and increases the likelihood of investments in cases where the induced additional benefit falls short of testing costs. -- Off-label use ; patent protection ; exclusivity ; liability

     

    Export in Literaturverwaltung   RIS-Format
      BibTeX-Format
    Hinweise zum Inhalt
    Quelle: Verbundkataloge
    Sprache: Englisch
    Medientyp: Ebook
    Format: Online
    ISBN: 9783867881272
    Weitere Identifier:
    hdl: 10419/29919
    Schriftenreihe: Ruhr economic papers ; 114
    Schlagworte: Arzneimittel; Gesundheitsrisiko; Arzneimittelrecht; Haftung; Ärzte; Patentrecht; Theorie
    Umfang: Online-Ressource (19 S.), graph. Darst.
    Bemerkung(en):

    Parallel als Druckausg. erschienen